Catalyst Wire Dossier Catalyst Wire Dossier

Zamtocabtagene Autoleucel

· Miltenyi Biomedicine GmbH
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Zamtocabtagene Autoleucel, covering 2024-11-20 to 2025-12-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Zamtocabtagene Autoleucel (MB-CART2019.1) in Pediatric Patients With R/R B-Cell Neoplasms [Phase 2]

See pricing